Recent Headlines
Within Pharmaceuticals
Steadfast Partners Helps OP Consulting Group NW Achieve CMMC Level 1 Self-Attestation
Steadfast Partners, a leading cybersecurity consultancy, is proud to announce its successful collaboration with OP Consulting Group NW, enabling the organization to complete its Cybersecurity Maturity Model Certification (CMMC) Level 1 self-attestation. This achievement underscores both... - January 12, 2026 - Steadfast Partners LLC
Global Diabetes and Endocrinology Summit 2026 to Convene International Experts in a Live Virtual Webinar
The Global Diabetes and Endocrinology Summit is an international scientific forum dedicated to advancing research, education, and collaboration in diabetes and endocrinology. The summit brings together experts from academia, clinical practice, and research institutions to share insights that drive innovation and improve patient outcomes worldwide. - January 09, 2026 - The Global Diabetes and Endocrinology Summit
Pharmacy XD Launches Nationally Licensed Direct-to-Patient Mail Order Pharmacy and Distribution Platform - Headquartered in Florida’s Fastest-Growing Healthcare Corridor
Pharmacy XD LLC, a fully licensed Florida Department of Health–approved national mail order pharmacy and distribution facility, today officially announces its direct-to-patient (DTP) platform. Positioned in the heart of one of Florida’s most dynamic healthcare and life sciences... - January 08, 2026 - Pharmacy XD LLC
IGETHI Welcomes You to January
A New Kind of Reset for a New Kind of Consumer. January is more than just a month on the calendar. It's a mindset. - January 07, 2026 - IGETHI
Cumberland Biotherapeutics Announces U.S. Launch of FDA Cleared DentoClude F, Complimentary Practice Program, and New Investor Fundraising Initiative
Cumberland Biotherapeutics, LLC, a dental innovation company integrating advanced bioactive glass with botanicals, today announced the U.S. launch of DentoClude F; DentoClude F is marketed under a commercial name for the Occlude® F Dentin Tubule Agent, which received FDA 510(k) clearance under... - December 30, 2025 - Cumberland Biotherapeutics, Inc
Techead Successfully Completes CMMC Level 1 Self-Attestation with Steadfast Partners’ Support
Techead, a leading provider of creative and IT staffing solutions, proudly announces the successful completion of its Cybersecurity Maturity Model Certification (CMMC) Level 1 Self-Attestation, reinforcing its commitment to safeguarding sensitive information and supporting clients in the defense... - December 29, 2025 - Steadfast Partners LLC
Nudge Establishes Leadership in 10% Nano Hydroxyapatite Toothpaste with Advanced REMIN+ Enamel Formula
Nudge, an Orlando, Florida–based oral care brand, advances fluoride free enamel care with its Nano Hydroxyapatite REMIN+ toothpaste, formulated around a high concentration 10% nano hydroxyapatite framework. Built by oral care experts with a passion over profits mindset, Nudge focuses on science backed formulation, transparency, and long term oral health. - December 29, 2025 - Nudge
Biostem Pharma Private Limited Becomes a Preferred Partner for Third-Party Pharma Manufacturing in India
Biostem Pharma Private Limited strengthens its position as a preferred partner for third-party pharma manufacturing in India. The company offers WHO-GMP-compliant production of tablets, capsules, syrups, and topical formulations, catering to both startups and established pharma brands. - December 29, 2025 - Biostem Pharma Pvt Ltd
Elait Health Recognised in the 2025 Gartner® Market Guide for Health Data Management Platforms
Elait Health today announced it has been recognized as a Representative Vendor in the 2025 Gartner® Market Guide for Health Data Management Platforms (HDMP), authored by Gartner Analyst Laura Craft in July 2025. This recognition highlights Elait Health’s momentum as it enters its Series A... - December 28, 2025 - Elait Health
Curasia Medilabs Private Limited Offers Monopoly-Based PCD Pharma Franchise Opportunities
Curasia Medilabs Private Limited announces monopoly-based PCD pharma franchise opportunities, offering exclusive territories, a diversified product range, and structured partner support across India. - December 27, 2025 - Curasia Medilabs Pvt.Ltd
AlloDx Unveils SuperNAT Platform: Breakthrough in Nephrin Antibody Detection for Podocyte Disease
The SuperNAT platform demonstrates 48.6% higher sensitivity than conventional ELISA, with its clinical validation data accepted for poster at ASN Kidney Week 2025. - December 25, 2025 - AlloDx
Orange Biotech Launches Innovative Third-Party Pharma Manufacturing Platform to Empower Indian Pharma Brands
Orange Biotech has launched an advanced Third-Party Pharma Manufacturing platform aimed at helping pharma companies, startups, and PCD franchise owners manufacture high-quality formulations efficiently. The platform offers WHO-GMP compliant production, customized product development, regulatory assistance, and pan-India distribution support, strengthening Orange Biotech’s position as a trusted B2B pharma solutions provider. - December 24, 2025 - Orange Biotech Pvt. Ltd.
Fleming Events Launches: Process Control Week: PID Tuning & Advanced Process Control Training, 9–13 March 2026, Amsterdam
Process Industries Face Rising Demand for Precision Control, Energy Efficiency, and Advanced Automation - December 19, 2025 - Fleming Events
Fleming Event Launches: In-Line Inspection and Inspection of Challenging Pipelines, 10–13 March 2026 in Amsterdam.
Pipeline Integrity Enters a New Risk Era - Inspection of Challenging Pipelines, 10–13 March 2026 in Amsterdam - December 19, 2025 - Fleming Events
Creative BioMart Enhances Host Cell Protein Mitigation Service to Strengthen Biotherapeutic Quality
Creative BioMart, a leading biotechnology company specializing in protein and biopharmaceutical solutions, has announced an enhancement to its host cell protein service. The upgraded offering introduces a more integrated and data-driven approach to identifying, quantifying, and reducing host cell... - December 11, 2025 - Creative BioMart
iFyber Expands Analytical Capabilities with Launch of Advanced LC-MS Services
iFyber has expanded its LC-MS analytical capabilities with advanced Orbitrap and UHPLC technology and the addition of industry experts Gary Schultz, PhD, and Brian Hoffman. The enhanced platform boosts sensitivity and analytical depth, supporting proteomics, metabolomics, E&L, and contaminant testing, strengthening iFyber’s mission to deliver high-quality, decision-driving preclinical insights. - December 10, 2025 - iFyber
DN Designs Launches Culture-Driven Branding Program to Support India’s Bharat-First Startup Wave
DN Designs launches a new Regional Culture-Driven Branding Program dedicated to helping Indian startups infuse regional languages, motifs, folklore, typography, and cultural storytelling into their brand identities and packaging — tailored for Bharat-first audiences. - December 01, 2025 - DN Designs
KMS Technology Unveils Refreshed Brand Identity to Reflect Its AI-First Evolution
KMS Technology, a strategic engineering company empowering businesses to turn bold ideas into high-impact solutions faster, today announced the launch of its refreshed brand identity. Featuring a new logo, color palette, and messaging, the rebrand signals the company’s transformation into an... - November 28, 2025 - KMS Technology
DDi Selected by a Large $2 Billion Medical Device Company to Streamline Regulatory Strategy, Intelligence and Assessments
DDi has been selected by a UK-based US $2B medical-device company to streamline its global regulatory strategy, intelligence operations, and regulatory assessments. The partnership strengthens compliance, accelerates market readiness, and leverages DDi’s advanced Visu regulatory-process platform. - November 24, 2025 - DDi LLC
Elabscience® Announces Antibody Technology Upgrade and Product Portfolio Enhancement
Elabscience® has announced a major upgrade to its antibody product portfolio with the adoption of recombinant rabbit monoclonal antibody technology. This innovation significantly enhances antibody specificity, reproducibility, and stability, meeting the growing global demand for high-performance research reagents. - November 19, 2025 - Elabscience
DelivHer Launches Anu™ by DelivHer: The First Disposable, Fluid-Retentive Menstrual Disc Designed Specifically for Heavy, Clot-Rich Flow
Anu™ by DelivHer stands apart from other menstrual discs and cups with its fluid-retentive Leak-Lock™ technology, locking in both fluid and clots for leak-free, extended wear and mess-free removal - finally providing real protection for women with heavier-than-normal cycles. - November 17, 2025 - Anu by DelivHer
Botanical Advocacy and Education (BAE) Launches to Promote Pure, Safe and Natural Solutions for Public Health
Botanical Advocacy and Education’s goal is to educate all people to the truth about botanicals. BAE is a Nonprofit that has been formed to reenergize Grassroots Advocacy and Education for the purpose of protecting the right of all American adults to use natural, unadulterated Botanicals for the purposes they choose. - November 17, 2025 - Botanical Advocacy and Education
Empact Health Consulting Launches to Redefine Healthcare Leadership with Compassion and Operational Excellence
Empact Health Consulting, a division of BFG Brown Financial Group, has launched to redefine healthcare leadership by combining strategic insight with compassion. The firm partners with hospitals, clinics, and healthcare organizations to strengthen culture, streamline operations, and enhance both employee well-being and patient outcomes. Founder Shawn T. Brown stated that Empact aims to “ensure compassion and efficiency coexist in every aspect of healthcare delivery. - November 13, 2025 - Empact Health Consulting
Parvus Therapeutics Reports Positive Phase 1 Results for Lead Autoimmune Treg Therapy, PVT201
PVT201 demonstrated favorable safety, predictable pharmacokinetics, and on-target pharmacodynamic activity in first-in-human study. - November 12, 2025 - Parvus Therapeutics U.S., Inc.
Healing the Invisible Wounds of War: Veterans Rebuild Lives After Combat
From the battlefield to civilian life, veterans reveal how understanding the mind helped them overcome post-service stress. - November 11, 2025 - Bridge Publications
Alera Bio Announces Appointment of Board of Directors
Alera Bio, a Chicago-based biotech developing therapies for rare neuroendocrine and neurological disorders, announced its inaugural Board of Directors. The board includes leaders in biopharma, clinical practice, and finance, such as Stephen Hill, Mark Prygocki, Renny Griffith, and Cassius Coleman. Their combined expertise will guide Alera Bio as it advances AB-101 for MCT-8 deficiency, an FDA-designated Rare Pediatric Disease therapy. - November 11, 2025 - Alera Bio
McObject Releases eXtremeDB/rt 2.0: Persistent Hard Real-Time Database System with Breakthrough Deadline and Flash Memory Control
McObject has released eXtremeDB/rt 2.0, the next evolution of its hard real-time database system. Now supporting persistent storage with deterministic flash management and advanced deadline scheduling, version 2.0 ensures predictable performance even under extreme workload and timing constraints. Ideal for aerospace, industrial, and safety-critical environments where timing precision truly matters. - November 04, 2025 - McObject
MVT Reports Breakthrough Preclinical Results for MVT‑101 in DVT Model
Microvascular Therapeutics, Inc. (MVT) today announced the publication of compelling preclinical data demonstrating that its proprietary phase‑shift microbubble platform, MVT‑101 (Solv), significantly enhances sonothrombolysis in a clinically relevant porcine model of deep vein thrombosis (DVT). The study appears in the peer‑reviewed journal Nanotheranostics (Vol. 9, Issue 3, 2025). - November 04, 2025 - Microvascular Therapeutics, Inc.
Ales for ALS Reaches 300+ Breweries in 2025 — Limited Spots Still Open to Join This Year
Ales for ALS™ announced today that more than 300 breweries across the United States and around the world have joined the 2025 program—poised to make this year one of the largest in the initiative’s 12-year history. Limited hop allocations remain available, and interested breweries are encouraged to enroll soon to secure one of the final shipments for the year. - October 31, 2025 - ALS Therapy Development Institute
True Marker Pharmaceuticals Hits Another Trust & Credibility Milestone
True Marker Pharmaceuticals, Inc., a licensed pharmaceutical wholesaler and repackager based in Phoenix, has earned BBB Accreditation, recognizing its commitment to ethical business practices, transparency, and regulatory compliance. The achievement aligns with True Marker’s expanding U.S. distribution network and reinforces its reputation as a trusted, DSCSA-compliant partner to independent pharmacies and healthcare providers nationwide. - October 28, 2025 - True Marker Pharmaceuticals, Inc.
Fleming Events Launches “Digital Quality in Clinical Trials” Training to Address New ICH E6 (R3) GCP Expectations
Fleming Events, a global provider of professional training and industry knowledge programs, has announced its upcoming masterclass Digital Quality in Clinical Trials, scheduled for 22–23 April 2026 in Vienna, Austria. The training comes at a critical time as regulators worldwide increase... - October 28, 2025 - Fleming Events
Liminatus Pharma, Inc. Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation
Liminatus Pharma, Inc. (NASDAQ: LIMN), La Palma, CA, a clinical-stage immuno-oncology company developing next-generation CD47-blockade therapies, announced today that it has entered into a Memorandum of Understanding (MOU) with Capital Trust Group Limited (CTG), a New Zealand-based investment... - October 27, 2025 - Liminatus Pharma, Inc
Finetech Updates All Plastic Ampoule Filling Machines; Now Introduces 1 New Series of Machines
Finetech has launched a new line of plastic ampoule filling machines designed to meet small-dose filling needs, suitable for filling solutions for test drugs, cosmetics, health products and food. - October 27, 2025 - Finetech
Precision Antibody to Present Expertise in High-Quality Biomarker Antibodies at the World ADC Conference 2025
Precision Antibody will showcase its biomarker antibody expertise at the World ADC Conference 2025 in San Diego, highlighting its role in advancing ADC and cancer biomarker research through high-quality monoclonal antibody development. - October 25, 2025 - Precision Antibody
New Study Shows Self-Guided Online Exercise Program Significantly Improves Strength and Reduces Fall Risk in Midlife and Older Women
A new study to be presented at The Menopause Society (TMS) 2025 Annual Meeting by Osteoboost Health shows that a self-guided, online exercise program led to rapid and clinically meaningful improvements in leg strength and endurance — key factors in reducing fall risk — in women ages 40... - October 21, 2025 - Osteoboost Health
Cancer Prevention Nanomedicine Platform Advances Toward Preclinical Development Phase
Elixira, a Swedish nanomedicine innovation designed to function as an artificial immune system for lifelong cancer prevention, is preparing for the preclinical development phase — marking a key milestone toward the world’s first preventive nanomedicine platform. The company has now... - October 19, 2025 - Elixira
New Report Uncovers What Sponsors Really Think About Preclinical Services and CROs
Life Science Strategy Group’s Preclinical Services Landscape and CRO Benchmarking Assessment Delivers Data-Driven Insights on Budgets, Outsourcing, Vendor Preferences, and Industry Shifts - October 16, 2025 - Life Science Strategy Group, LLC
Precision Antibody to Showcase High-Affinity, Epitope-Rich, and Fully Functional Antibody Capabilities at Antibody Engineering & Therapeutics Asia 2025
Precision Antibody will showcase its high-affinity, epitope-rich, and fully functional antibody development technologies at Antibody Engineering & Therapeutics Asia 2025 in Kyoto, highlighting innovations that accelerate discovery and therapeutic antibody programs worldwide. - October 15, 2025 - Precision Antibody
Hemanext Inc. Awarded $2.9M NIH Grant to Advance Clinical Initiatives in the United States
Hemanext Inc has been awarded a three-year Small Business Innovation Research Grant (SBIR) Phase II for a project titled, “Efficacy of Hypoxic Red Blood Cells Processed with the Hemanext ONE® System in Patients with Sickle Cell Anemia,” to support and strengthen the clinical efforts of hypoxically stored red blood cells (HRBC) in the United States. - October 14, 2025 - Hemanext
New GCP Training Aligned with ICH E6(R3) from Pharma Lessons
Pharma Lessons is pleased to announce the launch of its newly revised Good Clinical Practice (GCP) online training course, now fully aligned with the latest ICH GCP E6(R3) guidance. This update incorporates the key enhancements introduced by ICH E6(R3), including a stronger focus on risk-based... - October 14, 2025 - Pharma Lessons
Precision Antibody to Showcase Fully Human Monoclonal Antibody Development at the 19th Drug Discovery Strategic Summit in San Francisco
Precision Antibody will present its fully human monoclonal antibody development platform at the 19th Drug Discovery Strategic Summit, highlighting rapid, royalty-free antibody solutions advancing cancer research and drug discovery. - October 14, 2025 - Precision Antibody
Cellionyx Exits Stealth Mode with Cytomotion, an FDA-Registered Class I Electroceutical Device Set to Redefine Human Healing and Performance
Cellionyx today emerged from stealth to launch Cytomotion, a first-in-class, FDA-Registered Class I medical device. Shifting the paradigm to true cellular regeneration, Cytomotion utilizes precision-directed electrical fields to activate the body’s innate repair mechanisms. Validated through its licensee Equstech in the elite high performance equestrian sports market, the technology accelerates recovery from injury and proactively optimizes human performance. Commercial launch November 12, 2025. - October 13, 2025 - Cellionyx
IVC Hosts Charity Golf Tournament, Donates $100,000 to Support Local Communities
IVC proudly hosted its annual Charity Golf Tournament on October 8 at The Cliffs at Mountain Park Golf Club, bringing together employees, partners, and community members for a day of camaraderie, giving, and impact. As part of the event, IVC donated $50,000 each to March of Dimes in Anderson, SC,... - October 11, 2025 - International Vitamin Corporation
Radial Celebrates the Grand Opening of Its Second South Carolina Clinic in Downtown Conway
More than 60 community members and business leaders join for ribbon cutting ceremony with the Conway Chamber of Commerce. - October 11, 2025 - Radial
Abel Womack Launches Newly Redesigned Website
Enhancing Customer Experience Across Forklift, Automation, and Intralogistics Solutions - October 01, 2025 - Abel Womack Inc
Aquaterra Biotech Launches Integrated DNA-to-GMP CDMO Platform in Québec
Aquaterra Biotech Launches Integrated Microbial CDMO Platform from DNA Design to GMP Release Aquaterra Biotech announced an integrated contract development and manufacturing (CDMO) platform that advances microbial and recombinant programs from DNA design to GMP release and logistics. Headquartered... - September 30, 2025 - Aquaterra Biotech
The FOXG1 Research Foundation Announces FDA Award of Orphan Drug Designation for FRF-001 Gene Therapy, Following Rare Pediatric Disease Designation
The FOXG1 Research Foundation announced the FDA has granted Orphan Drug and Rare Pediatric Disease designations to FRF-001, its gene therapy for FOXG1 syndrome. FRF-001 marks a historic first: a parent-led foundation sponsoring its own international, multi-site clinical trial. - September 29, 2025 - FOXG1 Research Foundation
Alera Bio Announces Appointment of Executive Leadership Team
Alera Bio announced its executive team: Philip Vorhies (CEO), Peter Thomson (CFO), Eric Floyd, PhD (CRO), and Caitlin Murray (GC), supported by expert consultants. Founder Frank Jaeger noted their strength in biotech, finance, regulatory, and legal, positioning Alera to advance AB-101 for MCT-8 deficiency, a rare neurological disorder with FDA Rare Pediatric Disease designation. - September 26, 2025 - Alera Bio
Madison Avenue Group Announces Christine Nguyen as Official Partner
In 2021, Madison Avenue Group was founded with a clear mission: to help brands scale and grow through the power of influencer marketing. What began as a solo venture by founder Hollie Nguyen has now grown into a partnership built on strength, resilience, and vision. - September 26, 2025 - Madison Ave Group
New Chief Commercial Officer Joins Hemanext Team to Drive Execution
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, is pleased to welcome Mr. Shane Ray to the team as Chief Commercial Officer (CCO). In this role, Shane will lead the global commercial strategy and execution for Hemanext ONE®. - September 24, 2025 - Hemanext